Literature DB >> 27648773

Declines in Cancer Death Rates Among Children and Adolescents in the United States, 1999-2014.

Sally C Curtin, Arialdi M Minino, Robert N Anderson.   

Abstract

KEY
FINDINGS: Data from the National Vital Statistics System •During 1999-2014, the cancer death rate for children and adolescents aged 1-19 years in the United States declined 20%, from 2.85 to 2.28 per 100,000 population. •The cancer death rate for males aged 1-19 years in 2014 was 30% higher than for females. •Declines in cancer death rates during 1999-2014 were experienced among both white and black persons aged 1-19 years and for all 5-year age groups. •During 1999-2014, brain cancer replaced leukemia as the most common cancer causing death among children and adolescents aged 1-19 years, accounting for 3 out of 10 cancer deaths in 2014. Since the mid-1970s, cancer death rates among children and adolescents in the United States showed marked declines despite a slow increase in incidence for some of the major types (1-3). These trends have previously been shown through 2012. This data brief extends previous research by showing trends in cancer death rates through 2014 among children and adolescents aged 1-19 years in the United States. Cancer death rates for 1999-2014 are presented and trends are compared for both females and males, by 5-year age group, and for white and black children and adolescents. Percent distributions of cancer deaths among children and adolescents aged 1-19 years are shown by anatomical site for 1999 and 2014. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Year:  2016        PMID: 27648773

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  35 in total

1.  SOX2 immunity and tissue resident memory in children and young adults with glioma.

Authors:  Juan C Vasquez; Anita Huttner; Lin Zhang; Asher Marks; Amy Chan; Joachim M Baehring; Kristopher T Kahle; Kavita M Dhodapkar
Journal:  J Neurooncol       Date:  2017-06-15       Impact factor: 4.130

2.  Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model.

Authors:  Nina Richartz; Eva Duthil; Anthony Ford; Elin Hallan Naderi; Sampada Bhagwat; Karin M Gilljam; Marta Maria Burman; Ellen Ruud; Heidi Kiil Blomhoff; Seham Skah
Journal:  Blood Adv       Date:  2019-11-12

Review 3.  Pediatric Cancer Models in Zebrafish.

Authors:  Mattie J Casey; Rodney A Stewart
Journal:  Trends Cancer       Date:  2020-03-13

4.  Increasing value of autopsies in patients with brain tumors in the molecular era.

Authors:  Jared T Ahrendsen; Mariella G Filbin; Susan N Chi; Peter E Manley; Karen D Wright; Pratiti Bandopadhayay; Jessica R Clymer; Kee Kiat Yeo; Mark W Kieran; Robert Jones; Hart G Lidov; Keith L Ligon; Sanda Alexandrescu
Journal:  J Neurooncol       Date:  2019-09-30       Impact factor: 4.130

5.  Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.

Authors:  Samuel J Reddick; Olivia Campagne; Jie Huang; Arzu Onar-Thomas; Alberto Broniscer; Amar Gajjar; Clinton F Stewart
Journal:  Cancer Chemother Pharmacol       Date:  2019-08-07       Impact factor: 3.333

Review 6.  Immunotherapy for pediatric brain tumors: past and present.

Authors:  Jessica B Foster; Peter J Madsen; Meenakshi Hegde; Nabil Ahmed; Kristina A Cole; John M Maris; Adam C Resnick; Phillip B Storm; Angela J Waanders
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

Review 7.  Immune profiling of pediatric solid tumors.

Authors:  Rachael L Terry; Deborah Meyran; David S Ziegler; Michelle Haber; Paul G Ekert; Joseph A Trapani; Paul J Neeson
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

8.  Subependymal Giant-cell Astrocytoma Masquerading as Restrictive Eating Disorder and Depression in an Adolescent.

Authors:  Alicia Barnes; Maggie M Wang; Jordan Feltes; Je Ko; Miguel A Guzman
Journal:  Innov Clin Neurosci       Date:  2020-01-01

9.  Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.

Authors:  Jian Peng; Hao Zhou; Oliver Tang; Ken Chang; Panpan Wang; Xiaowei Zeng; Qin Shen; Jing Wu; Yanhe Xiao; Sohil H Patel; Chongyu Hu; Ke Jin; Bo Xiao; Jerrold Boxerman; Xiaoping Gao; Patrick Y Wen; Harrison X Bai; Raymond Y Huang; Li Yang
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

10.  Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.

Authors:  Ashley S Plant; Shohei Koyama; Claire Sinai; Isaac H Solomon; Gabriel K Griffin; Keith L Ligon; Pratiti Bandopadhayay; Rebecca Betensky; Ryan Emerson; Glenn Dranoff; Mark W Kieran; Jerome Ritz
Journal:  J Neurooncol       Date:  2018-01-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.